Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1988 Dec;74(3):398–403.

A study of lymphocyte kinetics in nasopharyngeal carcinoma with indium III oxine-labelled lymphocytes.

P N Cheng 1, W C Shiu 1, J O Leung 1, S K Ho 1, K K Wong 1, C Metreweli 1
PMCID: PMC1542032  PMID: 3148379

Abstract

The kinetics of lymphocyte migration in 12 pre-treatment patients with nasopharyngeal carcinoma (NPC) and three cancer controls in remission were studied with Indium III oxine-labelled autologous lymphocytes. The migratory patterns of the labelled lymphocytes were defined by serial gamma imaging and blood clearance of Indium over 72 h. Once in the systemic circulation the labelled lymphocytes migrated immediately to the liver and spleen. In all the subjects studied the lymphocytes began to migrate out of the liver at 0.5 h, only to return to the organ gradually between 2 and 72 h. In the control subjects the lymphocytes migrated out of the spleen from about 4 h. This coincided with a hump in the peripheral blood clearance curve after about 4 h signifying re-entry of the lymphocytes into the vascular space from the spleen. In the 'early' NPC subjects (Stage I-III) the rate at which the lymphocytes entered the spleen was much reduced from about 4 to 72 h, suggesting a prolonged transit time of the lymphocyte through the organ. However, there were still prominent humps in the blood clearance curves, suggesting significant re-entry of lymphocytes into the vascular space. In the 'late' NPC subjects (Stage IV-V), the activity of the spleen was low between 4 and 72 h and there was continuous sequestration of lymphocytes in the organ. Consequently the humps in the blood clearance curves were much reduced or absent. The activities of the metastatic lymph nodes were intense between 2 and 48 h, suggesting marked sequestration of lymphocytes in the diseased lymph nodes. Migration of lymphocytes in the metastatic area of the liver was notably absent and presented as cold areas on gamma scanning. The sequestration of lymphocytes in the spleen and metastatic lymph nodes in 'early' and 'late' NPC could lead to a contraction of intravascular lymphocyte pool and could explain the stage-dependent lymphopenia reported in NPC.

Full text

PDF
398

Images in this article

401Fig. 3
on p.401

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Björkholm M., Wedelin C., Holm G., Johansson B., Mellstedt H. Longitudinal studies of blood lymphocyte capacity in Hodgkin's disease. Cancer. 1981 Nov 1;48(9):2010–2015. doi: 10.1002/1097-0142(19811101)48:9<2010::aid-cncr2820480917>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  2. Blomgren H. Lymphopenia and breast metastasis. Int J Radiat Oncol Biol Phys. 1977 Nov-Dec;2(11-12):1177–1179. doi: 10.1016/0360-3016(77)90129-8. [DOI] [PubMed] [Google Scholar]
  3. Crowther D., Wagstaff J. Lymphocyte migration in malignant disease. Clin Exp Immunol. 1983 Mar;51(3):413–420. [PMC free article] [PubMed] [Google Scholar]
  4. Heier H. E., Normann T. Blood lymphocytes in Hodgkin's disease. Lymphocytopenia related to stages and histological groups. Scand J Haematol. 1974;13(3):199–202. doi: 10.1111/j.1600-0609.1974.tb00260.x. [DOI] [PubMed] [Google Scholar]
  5. Hsu M. M., Lin B. L. Characterization of T cell subsets using monoclonal antibodies in nasopharyngeal carcinoma patients. Ann Otol Rhinol Laryngol. 1986 May-Jun;95(3 Pt 1):298–301. doi: 10.1177/000348948609500317. [DOI] [PubMed] [Google Scholar]
  6. Krant M. J., Manskopf G., Brandrup C. S., Madoff M. A. Immunologic alterations in bronchogenic cancer. Sequential study. Cancer. 1968 Apr;21(4):623–631. doi: 10.1002/1097-0142(196804)21:4<623::aid-cncr2820210414>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  7. Lavender J. P., Goldman J. M., Arnot R. N., Thakur M. L. Kinetics of indium-III labelled lymphocytes in normal subjects and patients with Hodgkin's disease. Br Med J. 1977 Sep 24;2(6090):797–799. doi: 10.1136/bmj.2.6090.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Matsuda S., Uchida T., Kariyone S. Kinetic studies on lymphocytes labelled with indium 111-oxine in patients with chronic lymphocytic leukaemia. Scand J Haematol. 1985 Aug;35(2):210–218. doi: 10.1111/j.1600-0609.1985.tb01575.x. [DOI] [PubMed] [Google Scholar]
  9. McCluskey D. R., Roy A. D., Abram W. P., Martin W. M. T lymphocyte subsets in the peripheral blood of patients with benign and malignant breast disease. Br J Cancer. 1983 Feb;47(2):307–309. doi: 10.1038/bjc.1983.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wagstaff J., Gibson C., Thatcher N., Crowther D. The migratory properties of indium-111 oxine labelled lymphocytes in patients with chronic lymphocytic leukaemia. Br J Haematol. 1981 Oct;49(2):283–291. doi: 10.1111/j.1365-2141.1981.tb07225.x. [DOI] [PubMed] [Google Scholar]
  11. Wagstaff J., Gibson C., Thatcher N., Ford W. L., Sharma H., Benson W., Crowther D. A method for following human lymphocyte traffic using indium-111 oxine labelling. Clin Exp Immunol. 1981 Mar;43(3):435–442. [PMC free article] [PubMed] [Google Scholar]
  12. Wagstaff J., Gibson C., Thatcher N., Ford W. L., Sharma H., Crowther D. Human lymphocyte traffic assessed by indium-111 oxine labelling: clinical observations. Clin Exp Immunol. 1981 Mar;43(3):443–449. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES